Global Market Insights on Needle-Free Drug Delivery Systems: Insights and Forecast, 2018-2025: Emphasis on Product (Prefilled needle-free injection systems, Prefilled needle-free injection systems); Technology (Jet Injectors, Transdermal Drug Delivery Systems, Inhaler Technology); Application (Insulin Delivery, Vaccination, Pediatric Injections, Pain Management); Injection Mode (Powder injections, Liquid injections, Liquid injections); Source of Power (Spring Loaded Jet Injector, Gas Powered Jet Injector, Battery Powered Jet Injector) and Region
March 2019
122
About the Report
About the Report
The report published" Global Needle Free Drug Delivery Device Market Insights to 2025 - provides a comprehensive analysis of needle free drug delivery device market at global level. The report focuses on overall market size for needle free drug delivery services by products (Fillable and prefilled needle-free injection systems), by various applications (Insulin Delivery, vaccinations, paediatric injections, pain management, by technology (jet injectors, transdermal drug delivery systems, inhaler technology), by injection method (powder injections, liquid injections and depot or projectile injection), by source of power (spring load jet injector systems, gas powdered jet injector and battery powdered jet injector system) by different regions such as North America, Europe, Asia Pacific, and Rest of world.
The report also provides a holistic view of the overall needle free drug delivery device market as well as regulations, growth drivers, restraints and factor analysis in terms of top investments undertaken, top product launches, major merger and acquisitions.
For an in-depth market overview, the report also includes a region wise analysis. For all the top industry players, a detailed product description, short- and long-term strategies, financials, SWOT analysis and recent developments are also included in the global needle free drug delivery device report. In addition to this, Porter 5s along with market share of leading needle free drug delivery device companies by application (Antares Pharma, Inc., Consort Medical, Crossject Soci�t� Anonyme, Inovio Pharmaceuticals, Injex Pharma, Medical International Technology, Zosano Pharma, Valeritas, 3M and PharmaJet) have also been covered.
Needle Free Drug Delivery Device Market Size
In terms of revenue, the needle free drug delivery device in has registered a remarkable growth with positive CAGR during the forecasted period. The needle free drug delivery device market has witnessed an overall rise in needle free penetration as well as needle free drug delivery devices adoption in last few years. Increasing number of chronic diseases incidence, inclination towards self-administration of drugs, growing technological advancements in the devices has driven the growth prospects of the market. In addition, rising demand for needle free drug delivery device system and stringent government regulations undertaken has also considerably catalysed the growth potential of the respective market.
Global Needle Free Drug Delivery Device Market Segmentation
Segmentation by Product
Needle free drug delivery device market fetched maximum revenues from prefilled needle free system on account of contamination free drug delivery by self-injection and popularity among the aging population. On the other hand, fillable system is expected to display overwhelming growth in years to come.
Segmentation by Technology
Jet injector needle free drug delivery device technology held dominant share in needle free drug delivery device market while the highest CAGR primarily was derived from transdermal drug delivery systems followed by inhaler technology in needle free drug delivery device to soaring demand for Jet injector needle free drug delivery device.
Segmentation by Application
Insulin needle free drug delivery market held the prime share in needle free technology market wherein pain management is the second lead share in the respective segment as it prevents the negative impacts of procedural pain and distress.
Segmentation by Injection Method
In respect to injection method, liquid injections held prominent share in needle free drug delivery market followed by Powder Injections market in needle free technology owing to predict the proportion of dose that is to be delivered into the human body.
Segmentation by Source of Power
Gas powdered jet injector technology held dominant share in needle free drug delivery market while the highest contribution in CAGR primarily was derived by spring load jet injector systems in needle free technology. The spring is released by triggering the barrel, leading to administration of jet stream of the drugs into subcutaneous, intramuscular or transdermal delivery of a drug.
Segmentation by Region
North America held the major share owing to high awareness regarding benefits of needle-free drug delivery devices, presence of developing healthcare facilities, and R&D expenditure by government. However, Asia-Pacific region is expected to witness the highest growth during the analysed period.
Scope of the report:
Global Needle Free Drug Delivery Device Market
Market Segmentation
Market Insights, by Products
Fillable needle-free injection systems
Prefilled needle-free injection systems
Market Insights, by Technology
Jet Injectors
Transdermal Drug Delivery Systems
Inhaler Technology
Market Insights, by Injection Method
Powder Injections
Liquid injections
Depot or Projectile Injection
Market Insights, by Applications
Insulin Delivery
Vaccinations
Paediatric Injections
Pain Management
Market Insights, by Source of Power
Spring Load Jet Injector Systems
Gas Powdered Jet Injector
Battery Powdered Jet Injector System
Company Profiles
Antares Pharma, Inc.
Consort Medical
Crossject Soci�t� Anonyme
Inovio Pharmaceuticals
Injex Pharma
Medical International Technology
Zosano Pharma
Valeritas
3M
PharmaJet
Reasons to buy:
The study includes market sizing and forecasting analysis validated by authenticated key industry experts
The report presents a quick review of overall industry performance at one glance
The report covers in depth analysis of prominent industry peers with primary focus on key business financials, product portfolio, expansion strategies and recent developments
Detailed examination on drivers, restraints, key trends and opportunities prevailing in the industry.
Examination of industry attractiveness with the help of Porter's Five Forces analysis
The study comprehensively covers the market across different segments
Deep dive regional level analysis of the industry
Customization Areas:
The Global Needle Free Drug Delivery Device Market can be customized to regional/country level or any other market segment. Besides this, UMI understands that you may have your own business need, hence we also provide fully customised solutions to clients.
Products
Companies
Antares Pharma, Inc., Consort Medical, Crossject Societe Anonyme, Crossject Societe Anonyme, Injex Pharma, Medical International Technology, Zosano Pharma, Valeritas, 3M, PharmaJet
Table of Contents
Table of Contents
1. MARKET INTRODUCTION 12
1.1 Market Definition 12
1.2 Objective of the Study 12
1.3 Limitation 12
1.4 Stakeholders 13
1.5 Currency used in the Report 13
2. RESEARCH METHODOLOGY OR ASSUMPTION 14
2.1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14
2.1.1 Main objective of the Needle Free Drug Delivery Devices Market Study 15
3. REGULATORY FRAMEWORK AND KEY DEVELOPMENT 16
3.1 General Overview 16
3.1.1 North America 16
3.1.2 Europe 17
4. INDUSTRY PERFORMANCE 18
5. EXECUTIVE SUMMARY 20
6. MARKET OVERVIEW 23
6.1 Introduction 23
6.2 Market Dynamics 24
6.2.1 Market Trend & Drivers 24
6.2.2 Rising Prevalence of Chronic and Lifestyle Diseases 24
6.2.3 Inclination Towards Self Administration of Drugs 26
6.2.4 Growing Technological Advancements in the Devices 27
6.3 Market Challenges 27
6.3.1 Ambiguity in the Specifications of Needle Free Devices 27
6.3.2 Limitations associated with Micro Needle Patches 28
6.4 Market Opportunities 28
6.4.1 Increase in the number of start-ups and Investments 28
6.4.2 Growing Adoption in Emerging Countries of Asia-Pacific Region 30
7. KEY MARKET INDICATORS 31
7.1 General Overview 31
7.1.1 Demand and Supply Side Analysis 31
7.1.1.1 Top Winning Strategies 32
7.1.1.1.1 Top Product launches 32
7.1.1.1.2 Top Business Expansions & Investments 33
7.1.1.1.3 Top Acquisition and Collaborations 34
7.1.2 Needle-free injection technology manufacturing process value chain 35
8. MARKET INSIGHTS BY PRODUCT TYPE (2018-25) 37
8.1 General Overview 37
8.1.1 Prefilled needle-free injection systems 38
8.1.2 Fillable needle-free injection systems 39
9. MARKET INSIGHTS BY TECHNOLOGY (2018-25) 41
9.1 General Overview 41
9.1.1 Jet Injectors 42
9.1.2 Transdermal Drug Delivery Systems 43
9.1.3 Inhaler Technology 44
10. MARKET INSIGHTS BY APPLICATION TYPE (2018- 2025) 46
10.1 General Overview 46
10.1.1 Insulin Delivery 47
10.1.2 Vaccination 48
10.1.3 Pediatric Injections 49
10.1.4 Pain Management 50
11. MARKET INSIGHTS BY INJECTION METHODS 51
11.1 General Overview 51
11.1.1 Powder injections 52
11.1.2 Liquid injections 53
11.1.3 Depot or Projectile Injection 54
12. MARKET INSIGHTS BY SOURCE POWER 55
12.1 General Overview 55
12.1.1 Spring Loaded Jet Injector 56
12.1.2 Gas Powered Jet Injector 57
12.1.3 Battery Powered Jet Injector 58
13. MARKET INSIGHTS BY REGION 59
13.1 General Overview 59
13.1.1 North America Needle-Free Drug Delivery Market (2018-2025) 60
13.1.1.1 North America Needle Free Drug Delivery Market, by Product 62
13.1.1.2 North America Needle-Free Drug Delivery Market, by Technology 62
13.1.1.3 North America Needle-Free Drug Delivery Device Market, by Application 63
13.1.1.4 North America Needle-Free Drug Delivery Market, by Injection Method 63
13.1.1.5 North America Needle Free Drug Delivery Device Market by, Source of Power 64
13.1.2 Europe Needle-Free Drug Delivery Device Market (2018-2025) 64
13.1.2.1 Europe Needle-Free Drug Delivery Device Market, by Product 68
13.1.2.2 Europe Needle-Free Drug Delivery Device Market, by Technology 68
13.1.2.3 Europe Needle-Free Drug Delivery Device Market, by Application 69
13.1.2.4 Europe Needle Free Drug Delivery Device Market, by Injection Method 69
13.1.2.5 Europe Needle-Free Drug Delivery Device Market, by Source of Power 70
13.1.3 Asia Pacific Needle-Free Drug Delivery Device Market (2018-2025) 70
13.1.3.1 Asia Pacific Needle-Free Drug Delivery Device Market, by Product 74
13.1.3.2 Asia Pacific Needle-Free Drug Delivery Device Market, by Technology 74
13.1.3.3 Asia Pacific Needle Free Drug Delivery Device Market, by Application 75
13.1.3.4 Asia Pacific Needle-Free Drug Delivery Device Market, by Injection Method 75
13.1.3.5 Asia Pacific Needle-Free Drug Delivery Device Market, by Source of Power 76
13.1.4 Rest of World Needle-Free Drug Delivery Device Market (2018-2025) 76
13.1.4.1 RoW Needle-Free Drug Delivery Device Market, by Product 78
13.1.4.2 RoW Needle-Free Drug Delivery Device Market, by Technology 78
13.1.4.3 RoW Needle-Free Drug Delivery Device Market, by Application 79
13.1.4.4 RoW Needle Free Needle-Free Device Market, by Injection Method 79
13.1.4.5 RoW Needle-Free Drug Delivery Device Market by Source of Power 80
14. COMPETITIVE SCENARIO 81
14.1 Porter's Five forces analysis 81
14.1.1 Bargaining power of Buyer 81
14.1.2 Bargaining power of Supplier 82
14.1.3 The threat of new entrants 82
14.1.4 Availability of Substitute 83
14.1.5 Industry Rivalry 83
14.2 Global Needle-Free Drug Delivery Market Share Analysis, 2017 84
15. COMPANY PROFILES 85
15.1 Antares Pharma, Inc. 85
15.1.1 Key Facts 85
15.1.2 Business Description 85
15.1.3 Key Product/Services Offerings 86
15.1.4 SWOT Analysis 87
15.1.5 Key Financials 87
15.1.6 Revenue Split 88
15.1.7 Recent Developments 88
15.1.8 Funding 89
15.2 Consort Medical 90
15.2.1 Key Facts 90
15.2.2 Business Description 90
15.2.3 Key Product/Services Offerings 91
15.2.4 SWOT Analysis 92
15.2.5 Key Financials 92
15.2.6 Revenue Split 93
15.2.7 Recent Developments 93
15.3 Crossject Societe Anonyme 94
15.3.1 Key Facts 94
15.3.2 Business Description 94
15.3.3 SWOT Analysis 95
15.3.4 Key Financials 95
15.3.5 Revenue Split 96
15.3.6 Recent Developments 96
15.3.7 Funding 96
15.4 Inovio Pharmaceuticals 97
15.4.1 Key Facts 97
15.4.2 Business Description 97
15.4.3 SWOT Analysis 99
15.4.4 Key Financials 100
15.4.5 Revenue Split 100
15.4.6 Recent Developments 101
15.4.7 Funding 101
15.5 Injex Pharma 102
15.5.1 Key Facts 102
15.5.2 Business Description 102
15.5.3 Key Product/Services Offerings 102
15.5.4 SWOT Analysis 103
15.6 Medical International Technology 104
15.6.1 Key Facts 104
15.6.2 Business Description 104
15.6.3 Key Product/Services Offerings 105
15.6.4 SWOT Analysis 105
15.6.5 Key Financials 106
15.6.6 Revenue Split 106
15.6.7 Recent Developments 106
15.7 Zosano Pharma 107
15.7.1 Key Facts 107
15.7.2 Business Description 107
15.7.3 Key Product/Services Offerings 108
15.7.4 SWOT Analysis 108
15.7.5 Key Financials 109
15.7.6 Revenue Split 109
15.7.7 Recent Developments 110
15.8 Valeritas 111
15.8.1 Key Facts 111
15.8.2 Business Description 111
15.8.3 Key Product/Services Offerings 112
15.8.4 SWOT Analysis 112
15.8.5 Recent Developments 113
15.8.6 Funding 113
15.9 3M 114
15.9.1 Key Facts 114
15.9.2 Business Description 114
15.9.3 Key Product/Services Offerings 115
15.9.4 SWOT Analysis 116
15.9.5 Key Financials 116
15.9.6 Revenue Split 117
15.9.7 Recent Developments 117
15.9.8 Funding 117
15.10 PharmaJet 118
15.10.1 Key Facts 118
15.10.2 Business Description 118
15.10.3 Key Product/Services Offerings 118
15.10.4 SWOT Analysis 119
15.10.5 Recent Developments 120
15.10.6 Funding 120
List of Figure
FIG. 1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14
FIG. 2 Global Countries with most Adults Living with Diabetes, 2017 20
FIG. 3 Global Needle Free Drug Delivery Device Market 2018-2025 (USD Billion) 21
FIG. 4 Facts about Chronic Disease in the US, 2016 25
FIG. 5 Frequency of Needle Stick Injuries, by Devices 25
FIG. 6 Process for Self-Administration of Medicines (SAMS) 26
FIG. 7 Global Top Country, by Start-Up County 2017 29
FIG. 8 Global Funding, by Region 2016 & 2017 (USD billion) 29
FIG. 9 Health Expenditure Per Capita in Asia-Pacific, by Country 2015 (USD PPP) 30
FIG. 10 Needle-free Injection Technology Manufacturing Process 35
FIG. 11 Global Needle-Free Drug Delivery Device Market Share, by Product Type, 2017 & 2025 (%) 37
FIG. 12 Global Needle-Free Drug Delivery Device Market, by Product 2018-25 (USD Billion) 37
FIG. 13 Global Needle-Free Drug Delivery Device Market Share by Technology, 2017 & 2025 (%) 41
FIG. 14 Global Needle-Free Drug Delivery Device Market, by Technology, 2018-25 (USD Billion) 41
FIG. 15 Global Needle-Free Drug Delivery Device Market Share, by Application, 2017 & 2025 (%) 46
FIG. 16 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 46
FIG. 17 Global Needle-Free Drug Delivery Device Market Share by Injection Method, 2017 & 2025 (%) 51
FIG. 18 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 51
FIG. 19 Global Needle-Free Drug Delivery Device Market Share by Source Power, 2017 & 2025 (%) 55
FIG. 20 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 55
FIG. 21 Global Needle-Free Drug Delivery Device Market Share by Region, 2017 & 2025 (%) 59
FIG. 22 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 59
FIG. 23 Y-o-Y Growth rate of US Healthcare Expenditure (2011-2016), % 60
FIG. 24 Number and % of U.S. Population with Diagnosed Diabetes (2006-2015) 61
FIG. 25 Estimated age-adjusted prevalence of diagnosed diabetes by race/ethnicity and sex among adults aged ?18 US, 2013-2015 61
FIG. 26 Europe % of population over 65 years old, by Country 2017 65
FIG. 27 Number of people with diabetes in EU28, 2000 and 2017 65
FIG. 28 Europe % of Adult population with Diabetes, by Country 2017 66
FIG. 29 Estimated Incidence rate for all Cancers in Europe, by country, 2018 67
FIG. 30 HIV Prevalence in Asia-Pacific % of Population, by Country 2017 72
FIG. 31 Asia-Pacific Medical Equipment Market USD Billion (2015-2018) 72
FIG. 32 Ratio of people aged 15-64 to people aged over 65 years in Asia-Pacific, 2015 and 2050 73
FIG. 33 Porter's Five forces analysis of Global Needle-Free Drug Delivery Device 81
FIG. 34 Patent count of Smart Drug Delivery System 84
FIG. 35 Antares Pharma Inc. SWOT Analysis 87
FIG. 36 Antares Pharma Inc. Revenue Split, 2018 88
FIG. 37 Consort Medical SWOT Analysis 92
FIG. 38 Consort Medical Revenue Split, 2017 93
FIG. 39 Crossject Societe Anonyme SWOT Analysis 95
FIG. 40 Crossject Societe Anonyme Revenue Split, 2017 96
FIG. 41 Inovio Pharmaceuticals SWOT Analysis 99
FIG. 42 Inovio Pharmaceuticals Revenue Split, 2017 100
FIG. 43 Injex Pharma, SWOT Analysis 103
FIG. 44 Medical International Technology, SWOT Analysis 105
FIG. 45 Medical International Technology Revenue Split, 2018 106
FIG. 46 Zosano Pharma SWOT Analysis 108
FIG. 47 Zosano Pharma Revenue Split, 2017 109
FIG. 48 Valeritas, SWOT Analysis 112
FIG. 49 3M SWOT Analysis 116
FIG. 50 3M Revenue Split, 2017 117
FIG. 51 Medtronic Plc SWOT Analysis 119
List of Table
TABLE 1 Global Needle Free Drug Delivery Device Market by Region, 2018-25 (USD Billion) 22
TABLE 2 Examples of Prefilled Needle Free Devices 27
TABLE 3 Examples of Prefilled Needle-Free Devices 38
TABLE 4 Global Prefilled Needle-Free Injection System by Region, 2018-25 (USD Billion) 39
TABLE 5 Global Fillable Needle Free Injection System by Region, 2018-25 (USD Billion) 39
TABLE 6 Global Jet Injector Market Size by Region, 2018-25 (USD Billion) 42
TABLE 7 Global Transdermal Drug Delivery Systems, by Region, 2018-25 (USD Billion) 43
TABLE 8 Global Inhaler Technology by Region, 2018-25 (USD Billion) 44
TABLE 9 Global Needle-Free Insulin Delivery Market by Region, 2018-25 (USD Billion) 47
TABLE 10 Global Needle-Free Vaccination Market by Region, 2018-25 (USD Billion) 48
TABLE 11 Global Needle-Free Paediatric Injection Market by Region, 2018-25 (USD Billion) 49
TABLE 12 Global Needle-Free Pain Management Market, by Region, 2018-25 (USD Billion) 50
TABLE 13 Specification of Needle-Free Devices By Injection Methods 52
TABLE 14 Global Needle-Free Powdered Injection Market by Region, 2018-25 (USD Billion) 53
TABLE 15 Examples of Drugs Administered via Liquid Jet Injector 53
TABLE 16 Global Needle-Free Liquid Injection Market by Region, 2018-25 (USD Billion) 54
TABLE 17 Global Needle-Free Depot or Projectile Injection Market by Region, 2018-25 (USD Billion) 54
TABLE 18 Global Needle-Free Spring Loaded Jet Injector Market by Region, 2018-25 (USD Billion) 56
TABLE 19 Global Needle-Free Gas Powered Jet Injector Market by Region, 2018-25 (USD Billion) 57
TABLE 20 Global Needle-Free Battery Powered Jet Injector Market by Region, 2018-25 (USD Billion) 58
TABLE 21 North America Needle Free Drug Delivery Device by Product 2018-25 (USD Billion) 62
TABLE 22 North America Needle-Free Drug Delivery Device by Technology, 2018-25 (USD Billion) 62
TABLE 23 North America Needle-Free Drug Delivery Device by Application,2018-2025 (USD Billion) 63
TABLE 24 North America Needle-Free Drug Delivery Device by Injection Method, 2018-25 (USD Billion) 63
TABLE 25 North America Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (USD Billion) 64
TABLE 26 Europe Needle-Free Drug Delivery Device by Product, 2018-25 (USD Billion) 68
TABLE 27 Europe Needle-Free Drug Delivery Device by Technology, 2018-25 (USD Billion) 68
TABLE 28 Europe Needle-Free Drug Delivery Device by Application,2018-2025 (USD Billion) 69
TABLE 29 Europe Needle-Free Drug Delivery Device by Injection Method, 2018-25 (USD Billion) 69
TABLE 30 Europe Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (USD Billion) 70
TABLE 31 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in Asia-Pacific 71
TABLE 32 Asia Pacific Needle-Free Drug Delivery Device by Product, 2018-25 (USD Billion) 74
TABLE 33 Asia Pacific Needle-Free Drug Delivery Device by Technology, 2018-25 (USD Billion) 74
TABLE 34 Asia Pacific Needle-Free Drug Delivery Device by Application, 2018-2025 (USD Billion) 75
TABLE 35 Asia Pacific Needle-Free Drug Delivery Device by Injection Method, 2018-25 (USD Billion) 75
TABLE 36 Asia Pacific Needle-Free Drug Delivery Device by Source of Power, 2018-25 (USD Billion) 76
TABLE 37 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in RoW 77
TABLE 38 RoW Needle-Free Drug Delivery Device Market by Product, 2018-25 (USD Billion) 78
TABLE 39 RoW Needle-Free Drug Delivery Device Market by Technology, 2018-25 (USD Billion) 78
TABLE 40 RoW Needle-Free Drug Delivery Device Market by Application,2018-2025 (USD Billion) 79
TABLE 41 RoW Needle-Free Drug Delivery Device Market by Injection Method, 2018-25 (USD Billion) 79
TABLE 42 RoW Needle-Free Drug Delivery Device Market by Source of Power, 2018-25 (USD Billion) 80
TABLE 43 Antares Pharma Inc. Key Facts 85
TABLE 44 Product segmentation of Antares Pharma Inc. 86
TABLE 45 Antares Pharma, Inc. Growth Strategy 86
TABLE 46 Antares Pharma Inc. Financials US USD Million 87
TABLE 47 Consort Medical Key Facts 90
TABLE 48 Product segmentation of Consort Medical 91
TABLE 49 Consort Medical Growth Strategy 91
TABLE 50 Consort Medical Financials, USD Million 92
TABLE 51 Crossject Societe Key Facts 94
TABLE 52 Product segmentation of Crossject Societe Anonyme 94
TABLE 53 Crossject Societe Anonyme Growth Strategy 95
TABLE 54 Crossject Societe Anonyme Financials, USD Million 95
TABLE 55 Inovio Pharmaceutical Key Facts 97
TABLE 56 Product segmentation of Inovio Pharmaceuticals 98
TABLE 57 Inovio Pharmaceuticals Growth Strategy 99
TABLE 58 Inovio Pharmaceuticals Financials, USD Million 100
TABLE 59 Injex Pharma Key Facts 102
TABLE 60 Product segmentation of Injex Pharma 102
TABLE 61 Injex Pharma Growth Strategy 103
TABLE 62 Medical International Technology Key Facts 104
TABLE 63 Product segmentation of Medical International Technology 105
TABLE 64 Medical International Technology Growth Strategy 105
TABLE 65 Medical International Technology Financials, USD Million 106
TABLE 66 Zosano Pharma Key Facts 107
TABLE 67 Product segmentation of Zosano Pharma 108
TABLE 68 Zosano Pharma Growth Strategy 108
TABLE 69 Zosano Pharma Financials, USD Million 109
TABLE 70 Valeritas Key Facts 111
TABLE 71 Product segmentation of Valeritas 112
TABLE 72 Valeritas Growth Strategy 112
TABLE 73 3M Key Facts 114
TABLE 74 Product segmentation of 3M 115
TABLE 75 3M Growth Strategy 115
TABLE 76 3M Financials, USD Million 116
TABLE 77 PharmaJet Key Facts 118
TABLE 78 Product segmentation of PharmaJet 118
TABLE 79 Pharmajet Growth Strategy 11
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.